Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BGI partners with the University of Birmingham

Published: Wednesday, August 01, 2012
Last Updated: Wednesday, August 01, 2012
Bookmark and Share
Collaboration announced as a major joint initiative in environmental and human health research.

The new venture will provide a world-class research and training centre on Birmingham’s campus that integrates state-of-the-art approaches in molecular biology, including DNA sequencing, metabolomics and bioinformatics. Research will focus on organism responses to environmental change through to disease susceptibility and treatment.

This initiative expands the University of Birmingham’s recently announced £2 million research investment into the fields of environmental genomics and metabolomics to link genes and metabolite functions to the fate of natural populations coping with environmental challenges. The longer term impacts will be from using this information as an “early warning system” to better protect human and environmental health from chemical pollution and other stressors including climatic change.

This initiative also builds upon Birmingham’s Stratified Medicine and Systems Science for Health programs. The West Midlands Regional Genetics Laboratory, the largest NHS genetics facility in the UK, is at the forefront of introducing new genomic technologies into clinical pathways to transform the delivery of healthcare in the UK. The initiative will provide tools and additional skill sets to integrate genomics into mainstream medicine such as in cancer treatment.

Genomics has also been at the heart of bacteriological research in Birmingham for over a decade, now within a new Institute of Microbiology and Infection and an NIHR-funded Surgical Reconstruction and Microbiology Research Centre. This new BGI-Birmingham initiative will improve our understanding of the microbial communities that colonise the human body, evaluating how these change in health and disease with potential to augment, or even replace, traditional diagnostic bacteriology.

As one of the world’s largest genomics organisations, BGI has developed an integrative structure of research innovation, platform development and industrial application for promoting the advancement of innovative biology research, molecular breeding, healthcare and related fields. Although the headquarters of BGI is located in Shenzhen, China, it’s UK partnership with the University of Birmingham catalyses unique collaborations across the three distinct research themes given above, made possible by technologies and BGI’s expertise at processing and analysing unprecedented numbers of samples.

“This partnership’s mission is to solve 21st century challenges in environmental and human health. We appreciate this great opportunity to collaborate with scientists at the University of Birmingham. Combining two organisations’ world leading expertise and extensive research experience in these fields, I believe we could make more scientific breakthroughs for benefiting human life in the near future.”, said Yingrui Li, Vice President of BGI.

Under this agreement, BGI will work with the University to place an initial installation of sequencers and personnel within an interim joint laboratory to jump-start projects that together will help transform environmental and human health. Plans are underway to establish a made-for-purpose site for scaling-up the research activities. The scientific collaborations are further enhanced by plans to provide PhD level training opportunities to BGI staff, and student exchanges between Birmingham and Shenzhen.

Professors Jon Frampton and Kevin Chipman, who are Directors of Research for the College of Medical and Dental Sciences, and for the College of Life and Environmental Sciences at the University of Birmingham, commented that this integrative initiative will have a transformational impact on many areas of biological and biomedical research at the University of Birmingham.

“BGI’s significant presence at a UK institution of higher learning will reinforce how life-science education and basic research can improve human, environmental and economic wellbeing”, said Professor Adam Tickell, the University's Pro-Vice-Chancellor for Research and Knowledge Transfer. “We also expect innovations from the partnership’s activities that will translate into more collaborations, including with industry, to create new environmental and healthcare start-up companies and employment for our graduates.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Targeting Fat to Treat Cancer
Researchers develop novel cancer treatment that halts fat synthesis in cells, stunting tumors.
NIH Study Finds Link Between Depression, Gestational Diabetes
Researchers at NIH have discovered that the depression in early pregnancy doubles risk for gestational diabetes, and gestational diabetes increases risk for postpartum depression.
Gut Pathogens Thrive on Body's Tissue-Repair Mechanism
Researcher have discovered that harm caused by pathogens in the intestinal tract benefit from immune system response to damaged intestinal lining.
Cancer's Taste for Fat
Researchers discovered signalling pathway for fat burning is disrupted in certain cancers.
‘Tracking Bugs’ Reveal Secret of Cancer Cell Metabolism
Unexpected finding shows instead of throwing away valuable nutrients, the cells squeeze out every last drop of energy.
Ginger Nano-Lipid Particles May Improve Cancer Treatment
Edible ginger-derived nano-lipids show promise for effectively targeting and delivering chemotherapeutic drugs used to treat colon cancer.
Genetic Diversity of Enzymes Alters Metabolic Individuality
ToMMo scientists have shown that genetic polymorphisms, structural location of mutation and effect for phenotype correlate with each other.
Absolute Quantification of Mitochondrial Metabolites
Scientists have developed a method to quickly isolate and systematically measure metabolite concentrations within mitochondria.
Vitamin C May Boost Leukemia Treatment
Studies show that supplementing an epigenetic cancer drug with vitamin C enhanced the drug's effectiveness.
Demonstrating LNP Delivery of CRISPR Components
Intellia has presented data demonstrating in vivo gene editing ising liquid nanoparticles (LNPs) to deliver CRISPR/Cas9.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!